177 related articles for article (PubMed ID: 24825856)
1. Combination of conventional chemotherapeutics with redox-active cerium oxide nanoparticles--a novel aspect in cancer therapy.
Sack M; Alili L; Karaman E; Das S; Gupta A; Seal S; Brenneisen P
Mol Cancer Ther; 2014 Jul; 13(7):1740-9. PubMed ID: 24825856
[TBL] [Abstract][Full Text] [Related]
2. Redox-active cerium oxide nanoparticles protect human dermal fibroblasts from PQ-induced damage.
von Montfort C; Alili L; Teuber-Hanselmann S; Brenneisen P
Redox Biol; 2015; 4():1-5. PubMed ID: 25479549
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of tumor growth and invasion by redox-active nanoparticles.
Alili L; Sack M; von Montfort C; Giri S; Das S; Carroll KS; Zanger K; Seal S; Brenneisen P
Antioxid Redox Signal; 2013 Sep; 19(8):765-78. PubMed ID: 23198807
[TBL] [Abstract][Full Text] [Related]
4. CNP mediated selective toxicity on melanoma cells is accompanied by mitochondrial dysfunction.
Aplak E; von Montfort C; Haasler L; Stucki D; Steckel B; Reichert AS; Stahl W; Brenneisen P
PLoS One; 2020; 15(1):e0227926. PubMed ID: 31951630
[TBL] [Abstract][Full Text] [Related]
5. Combination Therapy of NSCLC Using Hsp90 Inhibitor and Doxorubicin Carrying Functional Nanoceria.
Sulthana S; Banerjee T; Kallu J; Vuppala SR; Heckert B; Naz S; Shelby T; Yambem O; Santra S
Mol Pharm; 2017 Mar; 14(3):875-884. PubMed ID: 28081601
[TBL] [Abstract][Full Text] [Related]
6. The role of GAPDH in the selective toxicity of CNP in melanoma cells.
von Montfort C; Aplak E; Ebbert L; Wenzel CK; Klahm NP; Stahl W; Brenneisen P
PLoS One; 2024; 19(3):e0300718. PubMed ID: 38512909
[TBL] [Abstract][Full Text] [Related]
7. Investigating temperature variability on antioxidative behavior of synthesized cerium oxide nanoparticle for potential biomedical application.
Pandey S; Kumari S; Manohar Aeshala L; Singh S
J Biomater Appl; 2024 Feb; 38(7):866-874. PubMed ID: 38173143
[TBL] [Abstract][Full Text] [Related]
8. Combinatory Cancer Therapeutics with Nanoceria-Capped Mesoporous Silica Nanocarriers through pH-triggered Drug Release and Redox Activity.
Singh RK; Patel KD; Mahapatra C; Parthiban SP; Kim TH; Kim HW
ACS Appl Mater Interfaces; 2019 Jan; 11(1):288-299. PubMed ID: 30539634
[TBL] [Abstract][Full Text] [Related]
9. Anti-cancer effects of cerium oxide nanoparticles and its intracellular redox activity.
Pešić M; Podolski-Renić A; Stojković S; Matović B; Zmejkoski D; Kojić V; Bogdanović G; Pavićević A; Mojović M; Savić A; Milenković I; Kalauzi A; Radotić K
Chem Biol Interact; 2015 May; 232():85-93. PubMed ID: 25813935
[TBL] [Abstract][Full Text] [Related]
10. Protection from radiation-induced pneumonitis using cerium oxide nanoparticles.
Colon J; Herrera L; Smith J; Patil S; Komanski C; Kupelian P; Seal S; Jenkins DW; Baker CH
Nanomedicine; 2009 Jun; 5(2):225-31. PubMed ID: 19285453
[TBL] [Abstract][Full Text] [Related]
11. Targeted Delivery and Redox Activity of Folic Acid-Functionalized Nanoceria in Tumor Cells.
Vassie JA; Whitelock JM; Lord MS
Mol Pharm; 2018 Mar; 15(3):994-1004. PubMed ID: 29397735
[TBL] [Abstract][Full Text] [Related]
12. Antioxidation of Cerium Oxide Nanoparticles to Several Series of Oxidative Damage Related to Type II Diabetes Mellitus In Vitro.
Zhai JH; Wu Y; Wang XY; Cao Y; Xu K; Xu L; Guo Y
Med Sci Monit; 2016 Oct; 22():3792-3797. PubMed ID: 27752033
[TBL] [Abstract][Full Text] [Related]
13. Combined cytotoxic and anti-invasive properties of redox-active nanoparticles in tumor-stroma interactions.
Alili L; Sack M; Karakoti AS; Teuber S; Puschmann K; Hirst SM; Reilly CM; Zanger K; Stahl W; Das S; Seal S; Brenneisen P
Biomaterials; 2011 Apr; 32(11):2918-29. PubMed ID: 21269688
[TBL] [Abstract][Full Text] [Related]
14. Cerium Oxide Nanoparticles Induce Oxidative Stress and Genotoxicity in Human Skin Melanoma Cells.
Ali D; Alarifi S; Alkahtani S; AlKahtane AA; Almalik A
Cell Biochem Biophys; 2015 Apr; 71(3):1643-51. PubMed ID: 25395198
[TBL] [Abstract][Full Text] [Related]
15. Accelerated and scarless wound repair by a multicomponent hydrogel through simultaneous activation of multiple pathways.
Bhattacharya D; Tiwari R; Bhatia T; Purohit MP; Pal A; Jagdale P; Mudiam MKR; Chaudhari BP; Shukla Y; Ansari KM; Kumar A; Kumar P; Srivastava V; Gupta KC
Drug Deliv Transl Res; 2019 Dec; 9(6):1143-1158. PubMed ID: 31317345
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of Different Compositions of Cerium Oxide Nanoparticles in Tumor-Stroma Interaction.
Sack-Zschauer M; Karaman-Aplak E; Wyrich C; Das S; Schubert T; Meyer H; Janiak C; Seal S; Stahl W; Brenneisen P
J Biomed Nanotechnol; 2017 Dec; 13(12):1735-1746. PubMed ID: 29490761
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, physico-chemical characterization, and antioxidant effect of PEGylated cerium oxide nanoparticles.
Xue Y; Balmuri SR; Patel A; Sant V; Sant S
Drug Deliv Transl Res; 2018 Apr; 8(2):357-367. PubMed ID: 28589454
[TBL] [Abstract][Full Text] [Related]
18. Dermal delivery of doxorubicin-loaded solid lipid nanoparticles for the treatment of skin cancer.
Tupal A; Sabzichi M; Ramezani F; Kouhsoltani M; Hamishehkar H
J Microencapsul; 2016 Jun; 33(4):372-80. PubMed ID: 27338131
[TBL] [Abstract][Full Text] [Related]
19. Combination Treatment of Murine Colon Cancer with Doxorubicin and Redox Nanoparticles.
Vong LB; Nagasaki Y
Mol Pharm; 2016 Feb; 13(2):449-55. PubMed ID: 26605906
[TBL] [Abstract][Full Text] [Related]
20. Selective cytotoxicity effect of cerium oxide nanoparticles under UV irradiation.
Zhang L; Jiang H; Selke M; Wang X
J Biomed Nanotechnol; 2014 Feb; 10(2):278-86. PubMed ID: 24738336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
